Use of dalbavancin in infective endocarditis: a case series

BACKGROUND: Infective endocarditis, typically caused by Gram-positive organisms such as viridans group streptococci and Staphylococcus aureus, is associated with high mortality and morbidity and requires aggressive, prolonged antimicrobial treatment and sometimes surgery. Dalbavancin, a lipoglycopep...

Descripción completa

Detalles Bibliográficos
Autores principales: Guleri, Achyut, More, Ranjit, Sharma, Rashmi, Wong, Michelle, Abdelrahman, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360293/
https://www.ncbi.nlm.nih.gov/pubmed/34396119
http://dx.doi.org/10.1093/jacamr/dlab099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360293/
https://www.ncbi.nlm.nih.gov/pubmed/34396119
http://dx.doi.org/10.1093/jacamr/dlab099

Ejemplares similares